Skip Navigation



Rheumatology Advance Access published online on December 24, 2008

Rheumatology, doi:10.1093/rheumatology/ken470
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
48/5/520    most recent
ken470v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Machado, L. A. C.
Right arrow Articles by McAuley, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Machado, L. A. C.
Right arrow Articles by McAuley, J. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Analgesic effects of treatments for non-specific low back pain: a meta-analysis of placebo-controlled randomized trials

L. A. C. Machado1, S. J. Kamper1, R. D. Herbert1, C. G. Maher1 and J. H. McAuley2

1The George Institute for International Health and 2Faculty of Health Sciences, The University of Sydney, Sydney, Australia.

Correspondence to: C. G. Maher, The George Institute for International Health, PO Box M201, Missenden Rd, Sydney, NSW 2050, Australia. E-mail: cmaher{at}george.org.au


   Abstract

Objective. Estimates of treatment effects reported in placebo-controlled randomized trials are less subject to bias than those estimates provided by other study designs. The objective of this meta-analysis was to estimate the analgesic effects of treatments for non-specific low back pain reported in placebo-controlled randomized trials.

Methods. Medline, Embase, Cinahl, PsychInfo and Cochrane Central Register of Controlled Trials databases were searched for eligible trials from earliest records to November 2006. Continuous pain outcomes were converted to a common 0–100 scale and pooled using a random effects model.

Results. A total of 76 trials reporting on 34 treatments were included. Fifty percent of the investigated treatments had statistically significant effects, but for most the effects were small or moderate: 47% had point estimates of effects of <10 points on the 100-point scale, 38% had point estimates from 10 to 20 points and 15% had point estimates of >20 points. Treatments reported to have large effects (>20 points) had been investigated only in a single trial.

Conclusions. This meta-analysis revealed that the analgesic effects of many treatments for non-specific low back pain are small and that they do not differ in populations with acute or chronic symptoms.

KEY WORDS: Meta-analysis, Randomized-controlled trial, Treatment efficacy, Low back pain, Placebo effect

Submitted 30 June 2008; revised version accepted 20 November 2008.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
L. A. C. Machado
Comment on: Analgesic effects of treatments for non-specific low back pain: a meta-analysis of placebo-controlled randomized trials: reply
Rheumatology, October 1, 2009; 48(10): 1333 - 1333.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
B. J. Sweetman
Comment on: Analgesic effects of treatments for non-specific low back pain: a meta-analysis of placebo-controlled randomized trials
Rheumatology, October 1, 2009; 48(10): 1332 - 1333.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. Artus and D. van der Windt
Small effects of treatments for non-specific low back pain: how can we improve patients' outcomes?
Rheumatology, May 1, 2009; 48(5): 464 - 465.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.